PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 66 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,987,153 | -51.3% | 239,038 | -19.3% | 0.00% | -100.0% |
| Q2 2023 | $8,182,150 | -53.6% | 296,240 | -61.4% | 0.00% | -50.0% |
| Q1 2023 | $17,640,770 | +368.7% | 766,990 | +122.4% | 0.00% | – |
| Q4 2022 | $3,763,371 | +44.0% | 344,947 | +11.3% | 0.00% | – |
| Q3 2022 | $2,614,000 | +7.6% | 310,049 | +0.9% | 0.00% | – |
| Q2 2022 | $2,430,000 | -58.6% | 307,230 | +23.9% | 0.00% | -100.0% |
| Q1 2022 | $5,870,000 | +43.5% | 247,876 | +107.2% | 0.00% | – |
| Q4 2021 | $4,091,000 | +300.3% | 119,607 | +107.5% | 0.00% | – |
| Q3 2021 | $1,022,000 | -65.4% | 57,651 | -12.3% | 0.00% | – |
| Q2 2021 | $2,950,000 | +172.9% | 65,733 | +57.6% | 0.00% | – |
| Q1 2021 | $1,081,000 | +298.9% | 41,715 | +210.8% | 0.00% | – |
| Q4 2020 | $271,000 | -77.2% | 13,423 | -77.9% | 0.00% | – |
| Q3 2020 | $1,190,000 | +822.5% | 60,873 | +732.2% | 0.00% | – |
| Q2 2020 | $129,000 | +134.5% | 7,315 | -6.0% | 0.00% | – |
| Q1 2020 | $55,000 | +5.8% | 7,778 | +5.2% | 0.00% | – |
| Q4 2019 | $52,000 | -55.9% | 7,391 | -24.6% | 0.00% | – |
| Q3 2019 | $118,000 | +18.0% | 9,804 | +18.6% | 0.00% | – |
| Q2 2019 | $100,000 | -82.8% | 8,268 | -82.2% | 0.00% | – |
| Q1 2019 | $583,000 | +227.5% | 46,354 | +75.5% | 0.00% | – |
| Q4 2018 | $178,000 | +27.1% | 26,419 | +94.3% | 0.00% | – |
| Q3 2018 | $140,000 | -2.1% | 13,600 | -35.9% | 0.00% | – |
| Q2 2018 | $143,000 | +1942.9% | 21,217 | +2262.7% | 0.00% | – |
| Q1 2018 | $7,000 | -78.8% | 898 | -44.3% | 0.00% | – |
| Q4 2017 | $33,000 | +200.0% | 1,611 | +165.8% | 0.00% | – |
| Q3 2017 | $11,000 | – | 606 | +30200.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 2 | -99.9% | 0.00% | – |
| Q1 2017 | $17,000 | -26.1% | 1,343 | +28.8% | 0.00% | – |
| Q4 2016 | $23,000 | – | 1,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |